Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvo save search
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published: 2023-06-22 (Crawled : 14:00) - biospace.com/
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
fda pancreas clearance insulin
Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - Pfizer, Sanofi, CSL Behring, Freeline, Genentech, Shire, Spark, Novo Nordisk, Sangamo, UBI, uniQure
Published: 2023-06-21 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.44%
H: 1.6%
C: 0.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.73%
H: 0.09%
C: -0.6%
companies market
Novo Nordisk takes actions to help protect US patients from unlawful sales of non-FDA approved medicines claiming to contain semaglutide
Published: 2023-06-20 (Crawled : 15:00) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.0%
H: 1.9%
C: 1.25%
sales approved
Novo Nordisk A/S - share repurchase programme
Published: 2023-06-19 (Crawled : 12:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
| Email alert
Add to watchlist
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-06-12 (Crawled : 11:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 1.35%
H: 0.22%
C: -0.89%
repurchase
Novo Nordisk invests DKK 15.9 bn in expansion of manufacturing facilities in Hillerød, Denmark
Published: 2023-06-12 (Crawled : 06:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 1.35%
H: 0.22%
C: -0.89%
expansion
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings
Published: 2023-06-06 (Crawled : 13:20) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 2.4%
H: 0.25%
C: -0.54%
MC | $53.99 -1.12% 0.0% 840K
|
Finance
|
| O: -1.08%
H: 5.06%
C: 3.17%
PRTK | $2.23 0.0% 4.8M
|
Health Technology
|
| O: 12.76%
H: 2.26%
C: -1.81%
pharmaceuticals acquired
Novo Nordisk A/S – Share repurchase programme
Published: 2023-06-06 (Crawled : 10:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 2.4%
H: 0.25%
C: -0.54%
repurchase
Novo Nordisk enters exclusive negotiations to acquire a controlling stake in BIOCORP, to be followed by a tender offer on all remaining shares
Published: 2023-06-05 (Crawled : 05:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.9%
H: -0.2%
C: -0.44%
acquire
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.74%
H: 1.4%
C: 0.35%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 1.32%
H: 0.31%
C: 0.12%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.6%
H: 1.07%
C: 0.29%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.84%
H: 1.62%
C: 1.33%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.03%
H: 0.84%
C: 0.82%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.37%
H: 1.34%
C: 1.14%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -0.45%
report global therapeutics growth market
Novo Nordisk A/S - share repurchase programme
Published: 2023-05-30 (Crawled : 11:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.72%
H: 0.02%
C: -1.23%
repurchase
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion for expanded use in children and adolescents with growth hormone deficiency
Published: 2023-05-26 (Crawled : 08:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.74%
H: 0.64%
C: -0.41%
sogroya chmp children positive growth hormone
Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discover and develop gene editing therapies for rare and cardiometabolic diseases
Published: 2023-05-24 (Crawled : 10:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.59%
H: 0.25%
C: -0.45%
rare life collaboration therapeutics
Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
Published: 2023-05-23 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.7%
H: 1.22%
C: -0.67%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.39%
H: 0.06%
C: -2.77%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.15%
H: 0.74%
C: -0.18%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.25%
H: 0.69%
C: -2.24%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.88%
H: 0.17%
C: -1.45%
ORMP A | $2.375 1.06% 1.05% 41K
|
Health Technology
|
| O: 0.9%
H: 10.29%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: -1.46%
report global protein therapeutics growth market
Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial
Published: 2023-05-22 (Crawled : 15:00) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.04%
H: 0.86%
C: 0.02%
obesity trial
Novo Nordisk A/S - share repurchase programme
Published: 2023-05-22 (Crawled : 12:20) - globenewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.04%
H: 0.86%
C: 0.02%
repurchase
Non-Alcoholic Steatohepatitis Biomarkers Market Booming: Projected Market Value of US$ 8177.9 billion and CAGR of 31.3%
Published: 2023-05-18 (Crawled : 10:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.11%
H: 0.19%
C: -0.63%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.44%
H: 0.51%
C: 0.43%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.49%
H: 0.42%
C: -0.37%
biomarkers market
Global Menopause Drug Market Trends and Growth Opportunity Report 2022-2023 & 2030
Published: 2023-05-17 (Crawled : 03:00) - prnewswire.com
SGIOY | $11.83 1.96% 160K
|
Manufacturing
|
| O: 0.88%
H: 2.07%
C: -1.04%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.49%
H: 0.02%
C: -0.82%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.25%
H: 0.03%
C: -1.15%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.49%
H: 0.03%
C: -0.3%
drug report global trends growth market
Bi-Specific MAbS Global Market Report 2023: Major Players Include Johnson & Johnson, Novartis, Hoffmann-La Roche, Novo Nordisk and Bayer
Published: 2023-05-16 (Crawled : 22:00) - prnewswire.com
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.49%
H: 0.02%
C: -0.82%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: -1.05%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.17%
C: -0.5%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.25%
H: 0.03%
C: -1.15%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.82%
H: 0.03%
C: -0.44%
report global market
Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
Published: 2023-05-16 (Crawled : 14:00) - biospace.com/
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.48%
H: 1.06%
C: 0.44%
ray therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.